Hirosaki University Graduate School of Medicine, Hirosaki (Japan)
Follow
Contributor content
Presentation
Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response
